What moves improves, أو زي ما بيقولوا عندنا : الحركة بركة. السكون والقاعدة والفراغ بيخليك فريسة سهلة للأفكار السلبية والأوجاع والمشاكل والشياطين بنوعيهم، الإنس والجن. اتحرك عشان تعرف تفلت منهم، والحركة هنا بكل معانيها.

NY Valves- It’s been a pleasure! Grateful for the opportunity to present and learn alongside such brilliant minds. Huge thanks to @Agoldsweig and Islam Elgendy for their invaluable guidance and support throughout this project. #NYValves2025 #CardioTwitter #MedTwitter

New guidelines for assessing Diastolic Dysfunction and diagnosing HFpEF by American Society of Echocardiography For more information read the full statement: bit.ly/3Gyh2n4

Great collaboration at Mayo Clinic CV with our stellar Ahmed K. Mahmoud GLP-1RA + SGLT2i therapy was associated with significantly improved outcomes at 12-month follow-up compared to SGLT2i therapy alone. sciencedirect.com/science/articl…

Full support for our chief, well deserved Ibrahim 👏🏻👏🏻

Our study on Lp(a) variability highlights the change of Lp(a) over time! While repeat testing may aid risk assessment, it does not impact management, as no treatments have shown outcome benefit in elevated Lp(a). Kamal Awad, MD

Quick review of EastAFNET trial which favors Rhythm control vs old AFFIRM trial!!

🚨 Now recruiting! One application = Advanced HF + Critical Care Cardiology Dual Track Fellowship 🎯 ❤️ Legendary CV team + HF innovation 🏥 Home of the Critical Care Cardiology Summit 💥 Pioneers in ECMO resuscitation Train where it happens. sites.google.com/umn.edu/umn-im…

Excited to give Grand Rounds at Mayo Clinic Arizona (MayoArizonaID) tomorrow! Had a lovely dinner tonight catching up with friends and meeting the wonderful faculty and fellows here.

#ASPC2025 — Great energy, insightful sessions, and passionate colleagues in preventive cardiology. Come check out our work from BMC - Brighton IM Residency South Track at Poster SP120! Ahmed K. Mahmoud #CVPrevention #PreventiveCardiology

Our great academic clinical investigator is absolutely rocking it!!

We are in the era of cause-directed HF therapy, treating amyloidosis, HCM, and now tachycardia-induced cardiomyopathy can lead to recovery, allowing patients to come off GDMT and remain stable!!!!

👏🏻👏🏻👏🏻

DIGIT-HF trial An old drug might be added to GDMT?! The study drug was digitoxin—not digoxin. They’re different molecular profiles. When HF hospitalisations were analysed alone, there was no improvement. Waiting for Digoxin trial “DECISION trial” nejm.org/doi/full/10.10…

He deserves the best, good luck Ziad!!

🏥Adults who use cannabis have a nearly fourfold higher likelihood for developing type 2 #diabetes than those who do not use cannabis, according to research presented at #EASD2025. EASD @ibrahim_kamel9 Boston Medical Center Boston U Chobanian & Avedisian School of Medicine healio.com/news/endocrino…

Hit a small but meaningful milestone, 200+ citations, much earlier than I expected! Grateful to my mentors and colleagues for their support. Excited to keep collaborating and growing on my path to becoming an academic physician. Reza Arsanjani Chadi Ayoub Richard Patten